(PharmaNewsWire.Com, March 06, 2018 ) The North America Prostate Cancer Market was worth $16.32 billion in 2016 and estimated to be growing at a CAGR of 8.97%, to reach $25.08 billion by 2021. North America is the largest market for prostate cancer. This is rising as there is constant input for innovative drugs to cure the diseases.
Prostate cancer is cancer which occurs in a mans prostate. It is one of the most widespread types of cancer in men. This type of cancer generally grows gradually and initially remains limited to the prostate gland where it may not cause severe harm. This market needs new drugs that will address the unmet needs low cost and enhanced survival time.
Market for Prostate cancer is increasing due to a rise in prostate cancer population. Prostate cancer market will also be increased by the expected approval of nine late-stage pipeline products within the forecast period. There has been much growth in the prostate cancer therapeutics market over the past decade, with a number of products targeting advanced forms of the disease and showing greatly increased efficacy over their predecessors. Side effects associated with the treatment of cancer are hindering the market growth.
The North America Prostate Cancer market is segmented on the basis of diagnostic techniques into Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA). Based on surgery the market is segregated into Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR). By radiation therapy, the market is bifurcated into External Beam Radiation Therapy and Brachytherapy. External bean radiation therapy segment is further divided among 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy. Brachytherapy segment is sub segmented into Permanent Brachytherapy and Temporary Brachytherapy. On the basis of chemotherapy, segments are Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine.
Based on geography the market is analysed under regions namely, USA and Canada. USA is leading the prostate cancer market in the world.
Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.
Scope of the Report Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
